Frank. Thank you,
the improvement our our business financial $X.X breakeven financial EBITDA, cash is discipline our is objectives year-over-year, evident achieving This $XXX,XXX expense tough of growth on comparison consumer million by last Tru Niagen breakeven. million net the loss and products and core legal to slightly discipline excluding quarter. was by Sequential We driven Horizons in quarter, key strong XXXX underlying and business sales with against financial the lower underlying we’ll path to a focus sales, expense compared essentially my progress I'll quarter net XXXX, a quarter, to performance. general on The adjusted of in in our results, measured $X.X discuss flow total as of third which second expense. continued a year-over-year and the administrative of higher third continue again P&L operational year-over-year delivered gross we purchased sales begin results, reflect review margins, then higher the sequential and percentage and advertising lower and trends.
For which Horizon Hong ended Tru of Niagen’s second our Horizon’s sales included ChromaDex $XX.X healthcare X% XX, the XXXX, donated $X.X who Ventures of million, million months Kong the up in XXXX $XX.X X% bottles to a mid-teens a sales three hospitals from quarter in were sequentially compared the the reported set to purchase net shareholder million height down September is workers Tru or the pandemic. during Niagen excluding of purchase.
sales Beauty expected, Niagen X% growth we e-commerce growth Tru Tru continue was Conversely, businesses, the double the the quarter, business our which and Watsons and in roughly second compared in and million were with expect in as we to quarter. up-sales sequential the from and experienced our $X.X third up quarter respectively in half prior by were quarter, Niagen Watsons this of both Ingredient in to the third $X.X Niagen to and headwinds the the year. lower Sales brands. XX% second driven million Importantly, Niagen
XXXX in of XX.X% third basis up was the of Our XX.X% in gross the quarter points from XX XXXX. margin second to quarter
initiatives. efficiency As prior quarter, from supply included rebate a basis last we points XXX a chain year reminder to related
for favorable overall in our $XX.X were the million, margins. improvement the supply drove million XXXX. quarter improvement gross million expenses XXXX the savings to with stronger. $X.X compared expense marketing underlying third Selling in second and $X.X quarter up million down mix our XXXX, of to scale initiatives, and Total compared Product of operating million chain in the was to XXXX, the was the second $X So and of consistent of quarter third expectations. $X.X quarter cost
net of of sales, the this of quarter up percentage a basis the second was As third XXX XXXX versus XXXX. quarter expenditure in points
such and monitor increased to adjust quarter the acquisition At e-commerce same we time, spending. financial daily outlook. spending year this to metrics, costs our continue messaging with full consistent We customer as
quarter this awareness but which in Some were and acquisition of increasing important for it's the brand customer building, a focused on a costs customer investments for the higher short-term, was long-term retention.
expense legal $X.X $X.X to quarter million this reported of G&A million $X.X expense quarter. As in included current quarter $X.X of million of was in fees and $X.X down and XXXX third the million of in severance million XXXX, the the versus second restructuring
was Excluding legal to and XXXX second up expense, G&A fees, quarter comparable $X.X million of third expense coronavirus. lower G&A XXXX by severance No been equity Legal compensation versus expense $X.X and set the expense. due million XXXX. California was dates in restructuring trial quarter quarter the the second compared have
patent in for trial December, investments in as Hearing of September claims XXXX Delaware and case, infringement prepared in the Markman ongoing the construction, Our we XXXX.
We York also incurred ongoing expenses New related in the discovery to litigation.
Delaware the overall quarter, we expected this lower the expense quarter driven and litigations. by to While, in these ramp New up was fourth than York legal expect
quarter a of or or loss share million loss a the our XXXX. was XXXX. of million $X.X $X.X cents compared common third for second as the operating the For The second loss $X.X per net of of of stockholders quarter of $X.XX attributable a $X.XX XXXX of share, loss to $X.X million versus third in for was million the quarter loss quarter XXXX, per
improved XX% XXX by legal Total year-over-year net highlights. third due a were in is being in administration initiatives the million expenses Moving the key organization General growth XX% expense. XX% to increased by with margin and by of to net to third by of expense XXXX, points. growth as measured basis Watsons realignment XX.X% the to to XX% e-commerce growth quarter marketing basis from sales Marketing savings compared and quarter percentage financial in lower Tru $X.X and has was of lower Gross sales XXXX. and Niagen, XXX efficiency selling results. compared points up our XX% year-over-year
improved driven by the our Finally, million P&L. operating loss year-over-year, across by $X.X areas of efficiencies all
excluding gauge net business legal legal new better towards performance and of to measure, non-GAAP income expenses loss excluding XXXX, underlying for adjusted You total and the is severance may stock ChromaDex legal flow income financial EBITDA, which quarter our we expense help restructuring related amortization, spending. total cash and tax, non-cash or In bad expenses, defines adjusted a interest, of compensation adjusted investors breakeven. expense expense. introduced second the total is depreciation, progress debt Elysium, EBITDA,
a included have in the GAAP reconciliation release slides. We to measure appropriate earnings our
versus $X.X profit excluding XXXX, XXXX. the million second total XXXX to of a to of I million of XXXX. we put previously average a this loss in foundational year-over-year, million $X.X million Furthermore, and $X.X from XXXX of in we third loss systems expense the legal of highlighted, of loss third Total XXXX of As in $X.X improvement was improved million XXXX quarter place. EBITDA adjusted in has quarterly in quarter the delivered processes in and in important as a million metric $X the approximately quarter year-to-date, in the breakeven compared third quarter of $X
assessment million higher expect not we coronavirus primarily of of business was forward. balance to $X.X this our time, have accessed the XXXX. To quarter versus the do this We successfully our our pandemic strategies the credit. with sheet $X Moving coronavirus the capital million investments. differences The managing and not moving have have in ended the implemented any chain capital. date, third working in driven risk manage $XX.X navigated of flow. the disruptions quarter by quarter supply working from we operations and and during million second At cash quarter In the committed was net cash in line XXXX, to used cash million $X.X
unchanged to our As is relates year, full outlook it our second our XXXX from quarter.
including growth, We growth top deliver our expect continued business. in line to e-commerce
e-commerce we changes to to XXXX. additional initiatives, savings our expect business. and design chain in growing margin a quarter late product which implemented mix favorable from The in cost of implemented continue supply due XXXX gross beginning first the expansion We
We of increase million, border million selling to in platforms awareness new market in and $X brand $X an continue expect including investments our including in in and investments China. to launches, marketing expense cross
continued from and marketing by strong driven and scale expect customers our sales We a of returning on selling business. expense percentage improvement sales as in net
Lastly, we continue remains expect the said, expense may metric, year comparable to up severance a improvement legal excluding legal restructuring year the bad campaigns G&A marketing debt full Elysium for expect as and XXXX. total excluding be key $X But will versus by $X we of year-over-year G&A by related XXXX expense expense in and a be XXXX million, driven R&D full million and significant fluctuations expense, expense investments. XXXX. there timing excluding we Adjusted our EBITDA, quarter-to-quarter
to higher believe the driven and higher likely can $XX cash decline. in flow Total be revenues, expense. will breakeven the to expenses quarterly we $XX million operating near-term, if continue million legal by We litigation achieve of at litigation ends costs
will to million approximately initiatives gross as As and levers deliver than the P&L a to result, exit objective we for we’ll this. believe remains sales higher XX% of on progress This achieve to margins all we've gross need we better the supply XXXX. to saving on We as achieve $XX important made on we this and are track commitment. of company, cost significant an continue execute manage margins in we slightly deliver chain is that
me the and agreement. supply the Science on touch economics Nestlé license Health we let conclude, of Before briefly
supply the Celltrient on launched mentioned, fees. Cellular update Nestlé launch with and Energy As their to royalties the online you product upfront We exclusivity fee wanted Tru of U.S. for recently Niagen, the accounting Rob related in and product the Niagen
the Niagen as were payment product certain The sale achieved. be Nestlé, as tied to they a ChromaDex, to will new As commercial to million launch milestone the launch up markets. which milestones Tru there to aggregate payable reminder, are of payments in is $X
upon of We cash be Niagen will The U.S. Niagen. million royalties related the the last and The $X million manufacturer exclusive over deferred crystalline on the forms to when launch fees to would fee be related related shipment deferred upfront chloride NR exclusivity revenue of recognized expect XXXX, provide fees The estimated relative expires. patent supply for the quarter. the of term to basis our term shipments fourth issued exclusivity will material recognized to of up and in launch term quarterly our collect upfront the recognized quarter, the current in payment be agreement. through $X revenue. related required and on the the exclusivity were contract. launch The the product revise and based the necessary. the is estimates We to the to quantities over of this The a our true of revenue as rights
and beyond. to Beyond significant royalty and Nestlé. partnership to expect revenues from meaningful from upfront and we by in be profits in XXXX. create business fee long-term Nestlé revenues But and potential our milestone driven is payments, would continue and XXXX XXXX most the There ingredients, sales payments to the with contribution be small
awareness years remain summary, team's EBITDA, we important our continued now like In science milestone here to-date. Tru distribution committed achieved and marketing an food to to we of questions. I'm very total proud Nestlé. ready Operator, excluding to execution a come. take in profitable In the programs and we're of profitable partnership adjusted addition, of with Nestlé, well-respected raised discipline. growth expense global delivering company the and expansion entire of through legal financial ChromaDex of proud its Niagen We're strategic
